Introduction
============

Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, having a mortality rate near 50% ([@b1-or-37-05-2633]). Recent studies have shown that these tumors retain multilineage differentiation processes similar to those of the normal intestinal epithelium, mainly the goblet cell and enterocyte lineages ([@b2-or-37-05-2633]). Furthermore, molecular classifications representing these cellular phenotypes can have prognostic value and be predictive of response to different therapeutic agents ([@b3-or-37-05-2633]).

Metallothioneins (MTs) are a family of low-molecular-weight, cysteine-rich proteins involved in zinc and redox metabolism. By chelating zinc ions through redox-active thiol groups, they have the capacity to regulate the exchangeable, loosely-bound pool of intracellular zinc, termed the 'labile' pool, which participates in zinc transfer reactions and intracellular signaling. Thus MTs have been implicated in many aspects of tumor biology, such as proliferation, differentiation, apoptosis, angiogenesis, redox and zinc homeostasis, anti-inflammatory reactions and immunomodulation ([@b4-or-37-05-2633]--[@b7-or-37-05-2633]). The human genome encodes at least 11 functional MT isoforms that share structural and functional similarities. Due to their structural similarity, commercially available antibodies do not distinguish between individual MT isoforms, and therefore their individual mRNA expression levels can be measured by qRT-PCR. However, due to the fact that they are variably expressed in tissues and induced by several stimuli, it is possible that different tumors express distinct MT genes, which could help explain the conflicting data on MT function in different tumor types ([@b6-or-37-05-2633],[@b7-or-37-05-2633]). We and others have previously shown that multiple MT1 isoforms and MT2A are downregulated during CRC progression (especially isoform MT1G) mainly through epigenetic mechanisms, and that this is associated with shorter patient survival ([@b8-or-37-05-2633]--[@b11-or-37-05-2633]). Several agents such as DNA methyltransferase inhibitors, histone deacetylase inhibitors or zinc are capable of re-inducing MT expression in colorectal tumors, which can slow down *in vivo* tumor growth and sensitize these tumors to chemotherapeutic agents ([@b12-or-37-05-2633]).

In order to help understand the phenotypic consequences of MT induction, in the present study we investigated the effects of stable overexpression of the most downregulated isoform in CRC, namely MT1G, on the HT-29 CRC cell line. We uncovered a new role for this isoform in modulating tumor differentiation and thus expand the mechanisms by which this gene may act as a tumor suppressor in CRC.

Materials and methods
=====================

### Reagents and cell lines

The MT1G cDNA was cloned into the pcDNA3.1/myc-His(−)A expression vector, resulting in an MT1G-myc fusion protein as previously described ([@b12-or-37-05-2633]). Sodium butyrate and N,N,N\',N\'-tetrakis(2-pyridylmethyl) ethylenediamine (TPEN) were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA), and FluoZin-3-AM (FZ) from Invitrogen (San Diego, CA, USA). The human CRC cell lines HT-29 and HCT116 were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA), maintained as previously described ([@b8-or-37-05-2633]), and subjected to STR profiling for authentication after all experiments were finalized. For post-confluent growth, day 0 was considered the day when cells reached 100% confluence, and fresh medium was replaced every 1--2 days thereafter.

### Animal studies and histological procedures

Eight- to 10-week-old male nude mice were subcutaneously injected (2×10^6^ cells each) with two independent clones of MOCK or MT1G^+^ cells (5 mice/group) and tumor size was measured with a caliper to calculate tumor volume using the formula: Tumor volume (mm^3^) = \[length (mm)\]×\[width (mm)\]^2^×π/6. All animal procedures were approved by the Institutional Animal Care Board of the Leloir Institute. After 50 days, tumors were excised, formalin-fixed and paraffin-embedded for histological examination. A fraction of each tumor was preserved in RNAlater medium (Ambion Inc., Austin TX, USA) at 4̊C for 24 h, and then stored at −80̊C. RNA was extracted from RNAlater-preserved tissues using the TRIzol method (Invitrogen), and quantification and quality control were performed with the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Paraffin sections (4 µm thick) were re-hydrated and stained with Alcian Blue stain (1% in 3% acetic acid, pH 2.5) or processed for immunohistochemistry using the Vectastain Universal Elite ABC kit (Vector Laboratories, Inc., Burlingame, CA, USA) with citrate buffer antigen retrieval and the following antibodies: anti-cytokeratin 20 (KS 20.8; Dako Corporation, Carpinteria, CA, USA) and anti-CDX2 (clone EPR2764Y; Cell Marque, Rocklin, CA, USA).

For transmission electron microscopy, freshly xenografted tumors were cut into small (\~1-mm thick) pieces and promptly fixed in 2.5% glutaraldehyde in phosphate-buffered saline (PBS) for 2 h, washed and fixed for 90 min in 1% osmium tetroxide in phosphate-buffered saline (PBS), de-hydrated in acetone gradients and included in resin. Semi-(0.5 µm) and ultra-thin (70 nm) sections were cut and contrasted in 2.5% uranyl-acetate, and visualized using a Zeiss EM 109T microscope coupled to a digital CCD Gatan ES1000W camera.

### Gene expression profile analysis and qRT-PCR

Total RNA was extracted, and mRNA expression was analyzed using an Agilent Custom microarray 8×15K (Agilent Technologies, Palo Alto, CA, USA), which contained 15,744 oligonucleotide probes representing \>8,200 different human transcripts. Two samples from each group were used to detect mRNA expression; each biological replicate was run in duplicate, and the fluorochromes were swapped to reduce dye-bias; in total eight 15K microarrays were scanned using the Axon Confocal Scanner 4000B (Molecular Devices, Sunnyvale, CA, USA) with optimized settings: dye channel, 635 nm, PMT=720, laser power, 30%, scan resolution, 10 nm; dye channel, 532 nm, PMT=540, laser power, 30%, scan resolution, 10 nm; line average, 4 lines. The data were analyzed using GenePix^®^ Pro 6 Microarray Acquisition and Analysis Software (Molecular Devices) and normalized with the MIDAS v2.2: Microarray Data Analysis System (TIGR\'s Microarray Data Analysis System). Normalization was necessary to compensate for variability between slides and fluorescent dyes. To this end we employed a locally weighted linear regression \[Lowess ([@b13-or-37-05-2633],[@b14-or-37-05-2633])\]; data were filtered using low-intensity cutoff and replicate consistency trimming.

The differentially expressed genes among the MT1G^+^, and control (MOCK) sets were identified using the significant analysis of microarray (SAM) statistical software from MultiExperiment Viewer (MeV) (TIGR\'s Microarray Data Analysis System). In the comparisons of MT1G^+^ vs. MOCK, the genes that were all upregulated in the comparisons were identified as the persistently upregulated genes, and the genes that were all downregulated in the comparisons were defined as the persistently downregulated genes.

The gene annotation enrichment analysis using Gene Ontology (GO) (<http://www.geneontology.org/>) and Kyoto Encyclopedia of Genes and Genomes (KEGG) (<http://www.genome.jp/kegg/>) data for gene sets was performed using Database for Annotation, Visualization, and Integrated Discovery (DAVID) software ([@b15-or-37-05-2633],[@b16-or-37-05-2633]). A Benjamini p-value of 0.05 was used in the analysis.

Quantitative reverse-transcription PCR (qRT-PCR) was used to quantify mRNA levels as previously described ([@b8-or-37-05-2633]). Briefly, PCR runs were carried out using SYBR Universal Master Mix (Applied Biosystems, Carlsbad, CA, USA), and relative expression levels were determined by the ΔΔCt method using ACTB gene expression to normalize all samples. The primers used are listed in [Table I](#tI-or-37-05-2633){ref-type="table"}.

### Alkaline phosphatase activity measurement

The activity of this enzyme was used as a marker of differentiation of HT-29 cells ([@b17-or-37-05-2633]). For this purpose, confluent cell lines were lysed in 10 mM Tris (pH 7.4), 1 mM MgCl~2~, 20 µM ZnCl~2~, 0.2% Triton X-100 + protease inhibitors, and incubated with NBT-BCIP as the chromogenic substrate for 16 h at 37̊C. The resulting brown precipitate was solubilized in 10% SDS, 10% HCl and absorbance was measured at 595 nm.

### siRNA transfection

Two siRNAs targeting the MT1G isoform (si1G.1 and si1G.2) and one targeting all functional MT-1 and MT-2 isoforms were previously validated ([@b12-or-37-05-2633]), and transfected at 125 nM using LF2000 (Invitrogen) as described by the manufacturer. After 24 h of siRNA treatment, medium was replaced with or without 2 mM sodium butyrate for 48 h, and cells were collected for RNA extraction or ALP activity measurement.

### Scratch assays and gelatin zymography

We used the scratch assay to estimate the migration capacities of MOCK and MT1G^+^ cell lines, which were plated in triplicate in 24-well plates until they reached confluence. Two perpendicular scratches were made with a pipette tip, after which the cells were washed thrice in PBS and replaced with 1% fetal bovine serum (FBS) medium. Areas with the same wound length were selected and photographed until complete wound closure. Wound closure at a given time t was calculated as: (initial wound length - wound length at time t)/initial wound length×100.

To determine gelatinase activity of matrix metalloproteinases (MMPs), upon reaching confluence medium was replaced with serum-free Dulbeccos modified Eagles medium (DMEM) for 24 h, and the conditioned medium was centrifuged at 1,200 × g for 5 min, and immediately loaded into 10% polyacrylamide electrophoretic gels with or without 2.5 mg/ml gelatin (Sigma-Aldrich) as described in ([@b18-or-37-05-2633]). Coomasie Blue staining of the non-gelatin gels were used as a loading control.

### Measurement of intracellular labile zinc

For this purpose we employed the cell-permeable zinc-specific fluorophore FZ as described in ([@b12-or-37-05-2633]). Briefly, cells were plated in triplicate in sterile plastic coverslips (for fluorescence microscopy) or in 96-well plates (for fluorimetric analysis), and incubated for 30 min at room temperature with 2 µM FZ in PBS, washed in PBS and incubated a further 30 min in PBS at room temperature. Propidium iodide staining was used to control for plating differences and data are expressed as normalized fluorescence FZ = (F - FTPEN)/(FZn - FTPEN), so as to get values relative to a 'maximum' intensity given by pretreatment with zinc 400 µM for 8 h (FZn, resulting in FZ=1) and a 'minimum' intensity given by 20 µM TPEN treatment during the final 30 min incubation of fluozin (FTPEN, resulting in FZ=0). This score allowed us to better compare results of the different experiments.

### Statistical analysis

Data are expressed as mean ± SEM and p-values \<0.05 were considered significant. Comparison of means was carried out using Student\'s t-test, with one-way ANOVA followed by Dunnett\'s post hoc t-test for three or more groups, or with two-way ANOVA followed by Bonferroni\'s post hoc t-test for two variables. GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA, USA) software was used for analysis.

Results
=======

### MT1G overexpression in the HT-29 CRC cell line

We stably expressed MT1G as a myc-epitope fusion protein in HT-29 cells. When grown *in vivo* as subcutaneous xenografts on nude mice, these MT1G^+^ cells grew at similar rates compared to the empty-vector ('MOCK')-transfected cells (data not shown), in stark contrast to the antiproliferative effects we had previously observed using the HCT116 cell line ([@b12-or-37-05-2633]). However, hematoxylin and eosin (H&E) staining ([Fig. 1A](#f1-or-37-05-2633){ref-type="fig"}) showed that MT1G^+^ tumors contained a higher number of mucin-containing, Alcian Blue-positive cells ([Fig. 1B](#f1-or-37-05-2633){ref-type="fig"}) that were confirmed to be goblet cells by transmission electron microscopy ([Fig. 1C](#f1-or-37-05-2633){ref-type="fig"}). Nuclear expression of the intestine-specific homeobox transcription factor CDX2 was markedly enhanced in the MT1G^+^ tumors, as shown by immunohistochemical staining on [Fig. 1D](#f1-or-37-05-2633){ref-type="fig"}, as was also the intensity of cytokeratin 20 ([Fig. 1E](#f1-or-37-05-2633){ref-type="fig"}). The latter also suggests that commitment to the enterocyte lineage may be enhanced as well. Indeed, both goblet-associated (*TFF3*, *ATOH1* and *MUC2*) and enterocyte-associated genes (*HSI*, *CA2* and *ALPI*) were overexpressed in the MT1G^+^ tumors by qRT-PCR analysis ([Fig. 1F](#f1-or-37-05-2633){ref-type="fig"}), suggesting that MT1G^+^ tumors are more differentiated than MOCK controls.

### Gene expression analysis of HT-29 MT1G^+^ tumors using cDNA microarrays

We then used cDNA microarrays to profile the mRNA expression of MOCK and MT1G^+^ HT-29 xenografts, derived from two different MT1G^+^ or MOCK clonal cell lines (MT1G-1 and MT1G-2, or MOCK-1 and MOCK-2, respectively). Gene expression profiles of the biological replicates were reproducible and highly correlated (Pearson\'s correlation coefficient 0.81). Analysis of data with Rank product analysis revealed significant gene expression differences among the groups, with a total of 305 known genes found to be consistently upregulated or downregulated in the MT1G^+^ tumors ([Table II](#tII-or-37-05-2633){ref-type="table"}). GO analysis indicated that several functional categories were enriched by DAVID, and included upregulated genes associated with cell differentiation, cell fate commitment and Notch signaling pathway, as well as downregulated genes in the categories of regulation of apoptosis, cell migration and cell proliferation ([Table III](#tIII-or-37-05-2633){ref-type="table"}). Differentially expressed genes were also analyzed for KEGG pathway enrichment and two significantly enriched pathways were identified between upegulated or downregulated genes: the Notch signaling pathway and pathways in cancer, respectively.

Given the finding of downregulated genes in the cell migration category, we performed migration 'scratch' assays in the HT-29 and HCT116 cell lines overexpressing MT1G, and found in both cell lines a statistically significant reduction in migration rates upon MT1G overexpression ([Fig. 2A and B](#f2-or-37-05-2633){ref-type="fig"}). Gelatin zymography using conditioned media from these cells, however, revealed no differences in MMP2 activity ([Fig. 2C](#f2-or-37-05-2633){ref-type="fig"}).

Next, in order to further investigate the involvement of MT1G in the differentiation of HT-29 cells, we used two different and well-known cell culture conditions to stimulate the *in vitro* differentiation of these cells: sodium butyrate (BUT) treatment ([@b19-or-37-05-2633]) and post-confluent cell growth ([@b20-or-37-05-2633]). We used *TFF3* and *MUC2* mRNA expression as surrogate markers for the goblet cell lineage, and *HSI* and *CA1* mRNAs, along with enzymatic alkaline-phosphatase activity (ALP) for enterocytes.

### Involvement of MT1G in butyrate-mediated differentiation of HT-29 cells

Sodium butyrate is a well-known inducer of differentiation in CRC cell lines ([@b21-or-37-05-2633]), and indeed, as shown in [Fig. 3A](#f3-or-37-05-2633){ref-type="fig"}, treatment with this agent dose-dependently induced differentiation as assessed by ALP activity. Concordantly, this agent also induced *MT1G* and *MT2A* mRNA levels, in close correlation to ALP activity (Pearson r=0.993, p=0.007 for *MT1G* and r=0.999, p=0.0006 for *MT2A*; [Fig. 3B](#f3-or-37-05-2633){ref-type="fig"}). To determine whether the induction of MTs has a functional role in butyrate-induced differentiation, we used siRNAs to inhibit the induction of only *MT1G* (si1G.1 and si1G.2) or of all MT1 and MT2 isoforms (siMTs), as previously described ([@b12-or-37-05-2633]). [Fig. 3C](#f3-or-37-05-2633){ref-type="fig"} shows that siRNA pre-treatment partially mitigated *MT1G* induction after BUT treatment and markedly, also diminished the induction of *CDX2* ([Fig. 3D](#f3-or-37-05-2633){ref-type="fig"}), and of goblet-cell marker *TFF3* ([Fig. 3E](#f3-or-37-05-2633){ref-type="fig"}). Notably, BUT treatment had no effect on mRNA levels of *MUC2*, as has been previously reported by others ([@b17-or-37-05-2633]) (data not shown). In contrast, although the enterocyte-specific markers *HSI* and *CA1* were markedly upregulated at 2 mM BUT, silencing of MTs had no effect on their induction ([Fig. 3F and G](#f3-or-37-05-2633){ref-type="fig"}), or on the cell-cycle arrest mediator *CDKN1A/p21* (data not shown), whereas ALP activity was only slightly, but significantly reduced ([Fig. 3H](#f3-or-37-05-2633){ref-type="fig"}).

We next treated HT-29 MOCK and MT1G^+^ cells with butyrate. Notably, as depicted in [Fig. 4A](#f4-or-37-05-2633){ref-type="fig"}, whereas *CDX2* mRNA levels were similarly induced, MT1G overexpression markedly enhanced the induction of *TFF3* ([Fig. 4B](#f4-or-37-05-2633){ref-type="fig"}), whereas it blunted that of *HSI* ([Fig. 4C](#f4-or-37-05-2633){ref-type="fig"}). Therefore, both silencing and overexpression of MT1G support the hypothesis that this gene favors goblet over enterocyte differentiation upon butyrate treatment of HT-29 cells.

### Involvement of MT1G in post-confluent differentiation of HT-29 cells

Next, we studied the expression of MT1G in the post-confluent growth of HT-29 cells, where this cell line is known to differentiate poorly ([@b20-or-37-05-2633]). In this setting, *MT1G* mRNA was transiently induced at day 1 post-confluence, after which its expression was significantly reduced ([Fig. 5A](#f5-or-37-05-2633){ref-type="fig"}). In contrast, *CDX2* and enterocyte-specific genes *HSI* and *CA1* were transiently induced at day 3, two days after *MT1G* induction ([Fig. 5B-D](#f5-or-37-05-2633){ref-type="fig"}). Notably, *TFF3* expression mirrors *MT1G* expression, until day 14 when it is induced again ([Fig. 5E](#f5-or-37-05-2633){ref-type="fig"}). These time-course analyses again favored the association of MT1G induction with goblet over enterocyte differentiation. Notably, as with BUT treatment, *MUC2* expression was not altered in this context ([Fig. 5F](#f5-or-37-05-2633){ref-type="fig"}). We were unable to perform siRNA-mediated silencing of MT1G in this setting, as cells did not survive in a totally confluent state for \>1 day after transfection.

When growing HT-29 MOCK and MT1G^+^ cells post-confluence, we noted no difference in the induction of ALP activity between these two cell lines ([Fig. 6A](#f6-or-37-05-2633){ref-type="fig"}). Notably however, in the latter, *CDX2* mRNA was induced at significantly higher levels ([Fig. 6B](#f6-or-37-05-2633){ref-type="fig"}) whereas *HSI* induction was abolished ([Fig. 6C](#f6-or-37-05-2633){ref-type="fig"}). While we noted no differences in the induction of *TFF3* mRNA (data not shown), our data also implies a role for MT1G expression in counteracting enterocyte differentiation of HT-29 cells.

### Labile zinc levels in butyrate-treated and post-confluent HT-29 cells

Given the close relationship between MTs and zinc biology, we analyzed the levels of intracellular labile zinc in both models of differentiation, using the zinc-specific fluorophore FZ. Notably, after 72 h of 2 mM BUT treatment, FZ intensity was significantly induced in the HT-29 cells ([Fig. 7A](#f7-or-37-05-2633){ref-type="fig"}). We used TPEN treatment to chelate intracellular labile zinc before the addition of butyrate, and found that this abolished both *CDX2* and *HSI* mRNA induction ([Fig. 7B and C](#f7-or-37-05-2633){ref-type="fig"}), but had no effect on *TFF3* levels ([Fig. 7D](#f7-or-37-05-2633){ref-type="fig"}). In the post-confluence model, as shown by fluorescence microscopy in [Fig. 7E](#f7-or-37-05-2633){ref-type="fig"} and by fluorimetry in [Fig. 7F](#f7-or-37-05-2633){ref-type="fig"}, FZ intensity was induced at day 2 and progressively increased thereafter. Given that TPEN exposure for \>6 h is toxic to HT-29 cells, we used daily 5-h TPEN treatments to evaluate the effect of labile zinc on goblet and enterocyte markers. Notably, *TFF3* mRNA expression was significantly induced at days 1--3 post-confluence in TPEN-treated cells ([Fig. 7G](#f7-or-37-05-2633){ref-type="fig"}), whereas there was no effect on either *CDX2* or *HSI* levels (not shown).

In summary, labile zinc was induced in both models of intestinal differentiation, and its chelation by TPEN treatment either inhibited enterocyte differentiation (butyrate model) or induced the expression of goblet-cell markers (post-confluency model).

Discussion
==========

In the present study, we uncovered a new role for MT1G in altering the differentiation properties of the HT-29 cell line. We previously showed that induction of MTs by HDACi agents such as trichostatin A and sodium butyrate (BUT) is at least partly responsible for their cytostatic effects on human CRC cell lines, and that exogenous MT1G overexpression in the colorectal HCT116 cell line resulted in growth inhibition in nude mouse xenografts ([@b12-or-37-05-2633]). Notably, whereas MT1G overexpression did not alter the *in vivo* xenograft growth rate of HT-29 cells, it markedly increased the number of goblet cells and differentiation markers of these tumors, both of the goblet and the enterocyte lineages. These effects were not readily observed in 2D culture (data not shown), suggesting that additional signals from the tumor microenvironment may be needed to fulfill this effect. The reasons for the different observed phenotypic consequences of MT1G overexpression in these two cell lines are unclear, but a possible explanation may stem from the differences in endogenous MT1G expression: HCT116 cells do not express MT1G due to promoter hypermethylation and therefore the impact of MT1G overexpression may be stronger than that in HT-29 cells, which express low, but detectable mRNA levels ([@b8-or-37-05-2633]).

In an effort to understand the molecular mechanisms underlying the altered differentiation of MT1G^+^ tumors, we performed mRNA expression profiling by cDNA microarrays. The expression of several genes involved in the regulation of cell differentiation was found to be altered, particularly in the Notch signaling pathway, whose inhibition is well known to stimulate goblet cell differentiation in the intestine through activation of ATOH1 ([@b22-or-37-05-2633]). Notably, markers of different sets of intestinal stem cell markers were differentially dysregulated in MT1G^+^ tumors, with upregulation of HOPX (expressed in quiescent stem cells) and downregulation of Lgr5 (in crypt base columnar stem cells), again suggesting altered differentiation hierarchies ([@b23-or-37-05-2633],[@b24-or-37-05-2633]). Further studies are warranted to explore this in further detail.

To further characterize the involvement of MT1G in colorectal differentiation, we relied on two well-studied cell culture conditions: sodium butyrate and post-confluent growth. We showed that endogenous MT1G induction was required for the induction of goblet cell markers by butyrate, and was temporally associated with such markers in the confluency model. Moreover, stable exogenous MT1G overexpression favored goblet and blunted enterocyte differentiation in both models. Previous studies have shown MTs to be upregulated *in vitro* upon CRC differentiation ([@b25-or-37-05-2633]), and demonstrated a role for MTs in modulating differentiation in different tissues, such as human salivary gland tumor cells (where MT1F overexpression resulted in slower growing and more differentiated tumors) ([@b26-or-37-05-2633]), leukemic ([@b27-or-37-05-2633]) neurons and glial ([@b28-or-37-05-2633]), and T cells ([@b29-or-37-05-2633]). However, to the best of our knowledge, this is the first study showing a direct functional involvement of a metallothionein isoform in CRC differentiation.

Labile zinc ions have been recognized as secondary messengers capable of transducing a wide variety of intracellular signals ([@b30-or-37-05-2633],[@b31-or-37-05-2633]), including differentiation ([@b32-or-37-05-2633]--[@b34-or-37-05-2633]). MTs can regulate labile zinc concentrations and zinc transfer to different cellular organelles ([@b35-or-37-05-2633]), as well as respond to changes in intracellular zinc ions ([@b36-or-37-05-2633]). We showed in the present study that labile zinc was increased during differentiation induced both by butyrate and confluency, and that this was required for enterocyte differentiation by butyrate, whereas it blunted goblet marker induction in post-confluency. While the reason behind the differences observed in both models are unclear, the overall effects of zinc induction favor an enterocyte over goblet differentiation. Notably, although labile zinc increases have already been reported to occur during butyrate-mediated differentiation of the HT-29 cell line and have been associated to defined stages of the cell cycle ([@b37-or-37-05-2633]), in the present study, we reported for the first time a functional consequence of labile zinc induction in this process. Previous studies in other tissues have shown that MTs transiently translocate to the nucleus during early phases of differentiation to release the zinc ions necessary for zinc-dependent transcription factors to execute the differentiation programs of adipocytes and myoblasts ([@b38-or-37-05-2633],[@b39-or-37-05-2633]). Although we previously showed that MTs in HT-29 are localized to the cytoplasm ([@b8-or-37-05-2633]), we were not able to detect a nuclear shift in either of the differentiation models that we used in the present study (data not shown), although this possibility should be studied in further detail.

Taking into account our results, we hypothesize that MT1G induction during differentiation may play a role in the chelation and re-distribution of intracellular labile zinc, perhaps modulating the activity of zinc-requiring transcription factors and enzymes, and stimulating the differentiation program of colorectal cells. *In vitro*, our results showed that MT1G favors a goblet over enterocyte differentiation, although our mouse xenografts assays suggest that *in vivo* the differentiation into enterocytes is also stimulated, perhaps as a compensatory mechanism or in a non-cell autonomous manner. The precise mechanisms whereby this occurs and the participation of MT1G (and other MTs) in labile zinc redistribution during differentiation need to be studied in further detail. Moreover, tumor classifications based on gene signatures associated with different cell types suggest that tumors of the more differentiated 'goblet-' or 'enterocyte-like' subtypes have a better prognosis than undifferentiated 'stem-like' subtype, as well as different responses to therapeutic agents. Therefore, better understanding of the molecular mechanisms that govern the differentiation processes of tumor cells may be of clinical relevance.

Overall, in the present study, we unveiled a pro-differentiation effect of MT1G on various CRC cells, thus proposing a new mechanism whereby MT1G may act as a tumor suppressor in this tumor type. Moreover, we established a functional consequence of transient increases in labile zinc upon differentiation stimuli, and support the need of further studies relating zinc signaling and differentiation, that may ultimately underlie tumor cell phenotypes and response to therapies.

The present study was funded by the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) (PIP no. 845-10 to M.B.), the Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT) (IP-PAE 2007, to J.M.), the Fundación Cáncer, the Fundación P. Mosoteguy, the Fundación Sales, and the Fundación María Calderón de la Barca, Buenos Aires, Argentina.
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![HT-29 MOCK and MT1G^+^ subcutaneous xenografts in nude mice. (A) H&E and (B) Alcian Blue stainings showing an increase in the number of mucin-like cells in the MT1G^+^ tumors. (C) Microphotograph of a goblet-like cell in MT1G^+^ tumors. (D) CDX2 and (E) keratin 20 immunohistochemistry. (F) Expression of enterocyte and goblet-associated differentiation markers, as assessed by qRT-PCR. AFC, average fold-change.](OR-37-05-2633-g00){#f1-or-37-05-2633}

![Wound healing 'scratch' assays in (A) HT-29 and (B) HCT116 MT1G^+^ cells showing decreased migration capacity, but no difference in MMP2 activity as measured by (C) gelatin zymography; \*p\<0.05, \*\*p\<0.01 and \*\*\*p\<0.001.](OR-37-05-2633-g01){#f2-or-37-05-2633}

![Butyrate mediates the differentiation of HT-29 cells. (A) Assessment of ALP enzymatic activity, 72 h after treatment. (B) Induction of MT1G and MT2A mRNA expression measured by qRT-PCR 72 h after treatment. (C-G) Expression of MT1G, CDX2, TFF3, HSI and CA1 as well as (H) ALP activity after siRNA-mediated silencing of MT1G or all MTs. AFC, average fold-change; \*p\<0.05, \*\*p\<0.01 and \*\*\*p\<0.001.](OR-37-05-2633-g02){#f3-or-37-05-2633}

![(A) *CDX2*, (B) *TFF3* and (C) *HSI* expression in MOCK and MT1G^+^ cells upon butyrate treatment. AFC, average fold-change; \*p\<0.05, \*\*p\<0.01 and \*\*\*p\<0.001.](OR-37-05-2633-g03){#f4-or-37-05-2633}

![Expression of (A) *MT1G*, (B) *CDX2*, (C) *HIS*, (D) *CA1*, (E) *TFF3* and (F) *MUC2* upon differentiation stimulated by post-confluent growth of HT-29 cells. AFC, average fold-change; \*p\<0.05, \*\*p\<0.01 and \*\*\*p\<0.001.](OR-37-05-2633-g04){#f5-or-37-05-2633}

![Effects of stable MT1G expression on post-confluent growth of HT-29 cells. (A) ALP activity. (B) *CDX2* and (C) *HSI* expression. AFC, average fold-change; \*p\<0.05, \*\*p\<0.01 and \*\*\*p\<0.001.](OR-37-05-2633-g05){#f6-or-37-05-2633}

![Labile zinc induction upon differentiation. (A) Butyrate induces intracellular labile zinc levels in HT-29 cells, as measured by fluorimetry using the Fluozin-3AM (FZ) probe. (B and C) Both *CDX2* and *HSI* induction by butyrate are blunted by TPEN pre-treatment, whereas there is no effect on (D) *TFF3* expression. (E and F) Labile zinc levels are also increased in the post-confluency differentiation model of HT-29 cells, as measured by (E) epifluorescence microscopy (F) and fluorimetry. (G) Daily doses of TPEN stimulate TFF3 expression of post-confluent cultures. AFC, average fold-change; \*p\<0.05, \*\*p\<0.01 and \*\*\*p\<0.001.](OR-37-05-2633-g06){#f7-or-37-05-2633}

###### 

Primer sequences.

  Gene     Forward primer              Reverse primer
  -------- --------------------------- -------------------------
  MT1G     CTTCTCGCTTGGGAACTCTA        AGGGGTCAAGATTGTAGCAAA
  MT2A     GCAACCTGTCCCGACTCTAG        TTGCAGGAGGTGCATTTG
  ACTB     GCCATCTCTTGCTCGAAGTCCAG     ATGTTTGAGACCTTCAACACCCC
  CDKN1A   AAGACCATGTGGACCTGT          GGTAGAAATCTGTCATGCTG
  HSI      GAGGACACTGGCTTGGAGAC        ATCCAGCGGGTACAGAGATG
  HALPI    GACCACTCCCATGTCTTCTCCTT     TCGCACGCCTGAGTTGAA
  CA2      CCGCGGACACACAGTGCAGG        CCAGTGCTCAGGTCCGTTGTGT
  CA1      CAGAACATACAGTGGATGGAGTCAA   GGCCTCACCAACCTTCATCA
  K20      AAATGCTCGGTGTGTCCTG         ACTTCCTCCTGATGCTCCTT
  ATOH1    CCCCGGGAGCATCTTG            GGGACCGAGGCGAAGTT
  TFF3     CTCCAGCTCTGCTGAGGAGT        GCTTGAAACACCAAGGCACT
  HMUC2    CAGCACCGATTGCTGAGTTG        GCTGGTCATCTCAATGGCAG
  CDX2     GATGGTGATGTAGCGACTGTAGTGA   CTCGGCAGCCAAGTGAAAAC

###### 

List of all significantly differentially expressed genes in MT1G^+^ vs. MOCK HT-29 xenografts.

  A, Upregulated genes                                                                                                                                        
  ------------------------ -------------- ----------------------------------------------------------------------------------------- ------- ----------------- ------------------
  NM_138444                KCTD12         Potassium channel tetramerisation domain containing 12                                    2.65    2.81E-06          80.00
  NM_000051                ATM            Ataxia telangiectasia mutated                                                             2.52    4.68E-06          91.77
  NM_175698                SSX2           Synovial sarcoma, X breakpoint 2                                                          3.06    6.56E-06          99.19
  NM_031964                KRTAP17-1      Keratin-associated protein 17-1                                                           2.35    2.25E-05          141.15
  NM_003357                SCGB1A1        Secretoglobin, family 1A, member 1 (uteroglobin)                                          2.19    2.72E-05          155.94
  NM_005430                WNT1           Wingless-type MMTV integration site family, member 1                                      2.40    2.81E-05          156.29
  NM_001031672             CYB5RL         Cytochrome b5 reductase-like                                                              2.37    3.18E-05          164.29
  NM_000546                TP53           Tumor protein p53                                                                         2.12    3.75E-05          168.99
  NM_001123065                            Chromosome 7 open reading frame 65                                                        2.04    4.59E-05          181.40
  NM_001443                FABP1          Fatty acid binding protein 1, liver                                                       2.27    5.99E-05          197.89
  NM_000364                TNNT2          Troponin T type 2 (cardiac)                                                               2.01    8.24E-05          216.07
  NM_001201                BMP3           Bone morphogenetic protein 3                                                              2.17    1.01E-04          224.84
  NM_031310                PLVAP          Plasmalemma vesicle-associated protein                                                    2.02    1.22E-04          239.78
  NM_182981                OSGIN1         Oxidative stress induced growth inhibitor 1                                               1.89    1.44E-04          249.22
  NM_139211                HOPX           HOP homeobox                                                                              1.88    1.65E-04          256.18
  NM_017774                CDKAL1         CDK5 regulatory subunit-associated protein 1-like 1                                       1.86    2.00E-04          271.00
  NM_001077195             ZNF436         Zinc finger protein 436                                                                   1.96    2.62E-04          289.52
  NM_000067                CA2            Carbonic anhydrase II                                                                     1.76    2.82E-04          295.37
  NM_015894                STMN3          Stathmin-like 3                                                                           1.17    2.86E-04          296.25
  NM_014237                ADAM18         ADAM metallopeptidase domain 18                                                           2.19    2.95E-04          298.48
  NM_182705                FAM101B        Family with sequence similarity 101, member B                                             1.81    4.28E-04          330.71
  NM_025191                EDEM3          ER degradation enhancer, α-mannosidase-like 3                                             1.78    4.56E-04          337.06
  NM_020639                RIPK4          Receptor-interacting serine-threonine kinase 4                                            1.70    4.56E-04          337.43
  NM_004557                NOTCH4         Notch 4                                                                                   1.70    4.77E-04          340.80
  NM_005618                DLL1           δ-like 1 (*Drosophila*)                                                                   1.70    5.05E-04          346.21
  NM_004001                FCGR2B         Fc fragment of IgG, low affinity IIb, receptor (CD32)                                     1.71    5.22E-04          349.94
  NM_001008225             CNOT4          CCR4-NOT transcription complex, subunit 4                                                 1.66    6.17E-04          367.80
  NM_170664                OTOA           Οtoancorin                                                                                1.64    6.23E-04          368.88
  NM_019845                RPRM           Reprimo, TP53-dependent G2 arrest mediator candidate                                      1.39    6.24E-04          369.37
  NM_033409                SLC52A3        Chromosome 20 open reading frame 54                                                       1.65    6.26E-04          369.79
  NM_001010879             ZIK1           Zinc finger protein interacting with K protein 1 homolog (mouse)                          1.59    6.68E-04          376.61
  NM_007365                PADI2          Peptidyl arginine deiminase, type II                                                      1.98    6.99E-04          381.36
  NM_007314                ABL2           v-abl Abelson murine leukemia viral oncogene homolog 2                                    0.99    7.21E-04          385.01
  NM_001080519             BAHCC1         BAH domain and coiled-coil containing 1                                                   1.58    7.93E-04          397.25
  NM_000584                CXCL8          Interleukin 8                                                                             1.68    9.46E-04          419.56
  NM_002649                PIK3CG         Phosphoinositide-3-kinase, catalytic, γ-polypeptide                                       1.74    1.07E-03          437.34
  NM_178311                GGTLC1         γ-glutamyltransferase light chain 1                                                       1.28    1.09E-03          440.27
  NM_001124756             PABPC1L        Poly(A) binding protein, cytoplasmic 1-like                                               1.51    1.11E-03          442.81
  NM_001010926             HES5           Hairy and enhancer of split 5 (*Drosophila*)                                              1.09    1.15E-03          446.74
  NM_152643                KNDC1          Kinase non-catalytic C-lobe domain (KIND) containing 1                                    1.85    1.18E-03          449.71
  NM_152279                ZNF585B        Zinc finger protein 585B                                                                  1.30    1.18E-03          450.06
  NM_003018                SFTPC          Surfactant protein C                                                                      1.51    1.20E-03          452.03
  NM_003460                ZP2            Zona pellucida glycoprotein 2 (sperm receptor)                                            1.79    1.23E-03          456.86
  NM_022101                               Chromosome X open reading frame 56                                                        0.84    1.30E-03          464.79
  NM_001136566             RAD21L1        RAD21-like 1 (*S. pombe*)                                                                 0.61    1.31E-03          465.53
  NM_019886                CHST7          Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7                                 1.49    1.43E-03          477.78
  NM_002410                MGAT5          Mannosyl (α-1,6-)-glycoprotein β-1,6-N-acetyl-glucosaminyltransferase                     1.37    1.49E-03          484.02
  NM_001130715             PLAC8          Placenta-specific 8                                                                       1.47    1.51E-03          485.05
  NM_012368                OR2C1          Olfactory receptor, family 2, subfamily C, member 1                                       1.42    1.60E-03          493.64
  NM_198463                C3ORF67        Chromosome 3 open reading frame 67                                                        1.55    1.72E-03          503.50
  NM_080647                TBX1           T-box 1                                                                                   1.01    1.74E-03          504.66
  NM_001136003             C2CD4D         C2 calcium-dependent domain containing 4D                                                 1.38    1.83E-03          512.27
  NM_014909                VASH1          Vasohibin 1                                                                               1.38    1.84E-03          512.54
  NM_002318                LOXL2          Lysyl oxidase-like 2                                                                      1.44    1.91E-03          518.96
  NM_031457                MS4A8          Membrane-spanning 4-domains, subfamily A, member 8B                                       1.36    2.17E-03          538.29
  NM_001146190             ZNF407         Zinc finger protein 407                                                                   1.35    2.20E-03          541.10
  NM_004375                COX11          COX11 cytochrome *c* oxidase assembly homolog (yeast)                                     1.37    2.36E-03          552.91
  NM_001040462             BTNL8          Butyrophilin-like 8                                                                       0.84    2.39E-03          554.54
  NM_001265                CDX2           Caudal type homeobox 2                                                                    1.33    2.44E-03          558.57
  NM_001013661             VSIG8          V-set and immunoglobulin domain containing 8                                              1.33    2.50E-03          563.31
  NM_019119                PCDHB9         Protocadherin-β9                                                                          1.32    2.51E-03          564.49
  NM_001144875             DOK3           Docking protein 3                                                                         1.29    2.54E-03          566.33
  NM_003722                TP63           Tumor protein p63                                                                         1.38    2.56E-03          569.10
  NM_006138                MS4A3          Membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)          1.58    2.73E-03          580.41
  NM_005427                TP73           Tumor protein p73                                                                         1.37    2.88E-03          589.30
  NM_003106                SOX2           SRY (sex determining region Y)-box 2                                                      1.07    3.12E-03          604.10
  NM_033318                SMDT1          Chromosome 22 open reading frame 32                                                       0.80    3.14E-03          605.59
  NM_012426                SF3B3          Splicing factor 3b, subunit 3, 130 kDa                                                    1.31    3.31E-03          615.60
  NM_002458                MUC5B          Mucin 5B, oligomeric mucus/gel-forming                                                    1.53    3.45E-03          623.75
  NM_001001411             ZNF676         Zinc finger protein 676                                                                   1.45    3.48E-03          625.90
  NM_000362                TIMP3          TIMP metallopeptidase inhibitor 3                                                         1.33    3.55E-03          629.94
  NM_014751                MTSS1          Metastasis suppressor 1                                                                   1.23    3.62E-03          633.32
  NM_201442                C1S            Complement component 1, s subcomponent                                                    0.91    3.63E-03          633.68
  NM_005961                MUC6           Mucin 6, oligomeric mucus/gel-forming                                                     1.21    3.92E-03          647.05
  NM_001002758             PRY2           PTPN13-like, Y-linked 2                                                                   1.47    3.99E-03          650.48
  NM_001135654             PABPC4         Poly(A) binding protein, cytoplasmic 4 (inducible form)                                   1.31    4.01E-03          651.26
  NM_014030                GIT1           G protein-coupled receptor kinase interacting ArfGAP 1                                    1.17    4.13E-03          657.53
  NM_001083537             FAM86B1        Family with sequence similarity 86, member B1                                             1.29    4.16E-03          658.91
  NM_001645                APOC1          Apolipoprotein C-I                                                                        1.20    4.27E-03          664.10
  NM_003226                TFF3           Trefoil factor 3 (intestinal)                                                             1.19    4.29E-03          664.92
  NM_005172                ATOH1          Atonal homolog 1 (*Drosophila*)                                                           1.26    4.31E-03          665.93
  NM_003708                RDH16          Retinol dehydrogenase 16 (all-*trans*)                                                    0.92    4.41E-03          670.22
  NM_002917                RFNG           RFNG O-fucosylpeptide 3-β-N-acetylglucosaminyltransferase                                 1.28    4.56E-03          677.43
  NM_016585                THEG           Theg homolog (mouse)                                                                      1.19    4.63E-03          681.11
  NM_007058                CAPN11         Calpain 11                                                                                1.51    4.73E-03          684.84
  NM_003759                SLC4A4         Solute carrier family 4, sodium bicarbonate co-transporter, member 4                      1.19    4.74E-03          685.17
  NM_020299                AKR1B10        Aldo-keto reductase family 1, member B10 (aldose reductase)                               1.17    4.77E-03          686.57
  NM_032133                MYCBPAP        MYCBP-associated protein                                                                  0.92    4.95E-03          693.39
  NM_001631                ALPI           Alkaline phosphatase, intestinal                                                          1.25    4.98E-03          695.09
  NM_002486                NCBP1          Nuclear cap binding protein subunit 1, 80 kDa                                             1.23    5.09E-03          699.73
  NM_001105659             LRRIQ3         Leucine-rich repeats and IQ motif containing 3                                            1.18    5.13E-03          702.05
  NM_014276                RBPJL          Recombination signal binding protein for immunoglobulin-κJ region-like                    1.15    5.29E-03          708.75
  NM_015461                ZNF521         Zinc finger protein 521                                                                   0.91    5.35E-03          711.10
  NM_001105662                            Ubiquitin specific peptidase 17                                                           1.21    5.63E-03          722.91
  NM_005068                SIM1           Single-minded homolog 1 (*Drosophila*)                                                    1.19    5.73E-03          726.21
  NM_018646                TRPV6          Transient receptor potential cation channel, subfamily V, member 6                        0.64    6.05E-03          739.17
  NM_139026                ADAMTS13       ADAM metallopeptidase with thrombospondin type 1 motif, 13                                0.84    6.31E-03          749.50
  NM_152749                ATXN7L1        Ataxin 7-like 1                                                                           0.75    6.31E-03          749.64
  NM_019034                RHOF           Ras homolog gene family, member F (in filopodia)                                          1.21    6.35E-03          751.22
  NM_017592                MED29          Mediator complex subunit 29                                                               0.92    6.38E-03          752.10
  NM_206965                FTCD           Formiminotransferase cyclodeaminase                                                       1.16    6.40E-03          752.88
  NM_020063                BARHL2         BarH-like homeobox 2                                                                      1.10    6.41E-03          753.43
  NM_016338                IPO11          Importin 11                                                                               0.74    6.51E-03          756.92
  NM_001109997             KLHL33         Kelch-like 33 (*Drosophila*)                                                              1.15    6.61E-03          761.02
  NM_004235                KLF4           Kruppel-like factor 4 (gut)                                                               0.96    6.64E-03          762.27
  NM_172365                PPP1R36        Protein phosphatase 1, regulatory subunit 36                                              0.93    6.74E-03          765.82
  NM_003665                FCN3           Ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen)                        1.23    6.86E-03          770.05
  NM_017910                TRMT61B        tRNA methyltransferase 61 homolog B (S. cerevisiae)                                       0.97    7.11E-03          778.71
  NM_031459                SESN2          Sestrin 2                                                                                 0.27    7.16E-03          780.18
  NM_203458                NOTCH2NL       Notch 2 N-terminal like                                                                   0.59    7.16E-03          780.21
  NM_002203                ITGA2          Integrin, α2 (CD49B, α2 subunit of VLA-2 receptor)                                        1.20    7.16E-03          780.44
  NM_138337                CLEC12A        C-type lectin domain family 12, member A                                                  1.32    7.22E-03          782.42
  NM_020533                MCOLN1         Mucolipin 1                                                                               0.51    7.33E-03          786.12
  NM_022481                ARAP3          ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3                                 1.11    7.42E-03          789.36
  NM_001105578             SYCE2          Synaptonemal complex central element protein 2                                            1.13    7.66E-03          797.43
  NM_021969                NR0B2          Nuclear receptor subfamily 0, group B, member 2                                           1.16    7.68E-03          798.17
  NM_015852                ZNF117         Zinc finger protein 117                                                                   1.18    7.69E-03          798.86
  NM_023946                LYNX1          Ly6/neurotoxin 1                                                                          1.10    7.89E-03          805.77
  NM_001039887             PROSER3        Chromosome 19 open reading frame 55                                                       1.17    7.94E-03          807.24
  NM_015184                PLCL2          Phospholipase C-like 2                                                                    1.06    8.02E-03          809.76
  NM_004938                DAPK1          Death-associated protein kinase 1                                                         0.54    8.06E-03          811.54
  NM_004755                RPS6KA5        Ribosomal protein S6 kinase, 90 kDa, polypeptide 5                                        1.04    8.21E-03          816.35
  NM_001007532             STH            Saitohin                                                                                  1.17    8.24E-03          817.51
  NM_002613                PDPK1          3-Phosphoinositide-dependent protein kinase-1                                             1.10    8.34E-03          820.46
  NM_006620                HBS1L          HBS1-like (S. cerevisiae)                                                                 1.04    8.46E-03          824.24
  NM_003382                VIPR2          Vasoactive intestinal peptide receptor 2                                                  0.77    8.55E-03          826.94
  NM_203486                DLL3           δ-like 3 (*Drosophila*)                                                                   1.07    8.56E-03          827.15
  NM_018010                IFT57          Intraflagellar transport 57 homolog (*Chlamydomonas*)                                     0.92    8.74E-03          833.66
  NM_001135816             CXORF56        C1QTNF9B antisense RNA 1 (non-protein coding)                                             0.87    8.76E-03          834.30
  NM_033133                CNP            2′,3′-Cyclic nucleotide 3 phosphodiesterase                                               1.02    8.84E-03          836.32
  NM_005199                CHRNG          Cholinergic receptor, nicotinic, γ                                                        0.98    9.01E-03          841.20
  NM_182765                HECTD2         HECT domain containing 2                                                                  0.79    9.12E-03          844.85
  NM_001145290             SLC37A2        Solute carrier family 37 (glycerol-3- phosphate transporter), member 2                    0.90    9.15E-03          845.70
  NM_001195252             APTX           Aprataxin                                                                                 1.05    9.31E-03          850.77
  NM_001251964             TP53AIP1       Tumor protein p53-regulated apoptosis inducing protein 1                                  1.26    9.35E-03          851.82
  NM_198270                NHS            Nance-Horan syndrome (congenital cataracts and dental anomalies)                          1.13    9.53E-03          857.71
  NM_000578                SLC11A1        Solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1       1.06    9.63E-03          859.97
  NM_002139                RBMX           RNA binding motif protein, X-linked                                                       1.06    9.65E-03          860.47
  NM_000435                NOTCH3         Notch 3                                                                                   1.10    9.71E-03          862.14
  NM_033066                MPP4           Membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4)                          1.12    9.87E-03          867.43
                                                                                                                                                              
  B, Downregulated genes                                                                                                                                      
                                                                                                                                                              
  Gene reference           Gene symbol    Name                                                                                      Mean    P-values (Down)   RP-values (Down)
                                                                                                                                                              
  AJ298317                 MUC5AC         Mucin 5AC, oligomeric mucus/gel-forming                                                   −2.54   8.43E-06          112.88
                                                                                                                                                              
  AF547222                 LOC280665      Anti-CNG α1 cation channel translation product-like                                       −2.76   1.31E-05          123.92
  AK097187                 NQO2           NAD(P)H dehydrogenase, quinone 2                                                          −2.48   3.75E-05          169.61
  AK128551                 RNF216         Ring finger protein 216                                                                   −2.19   6.09E-05          198.31
  BC062748                 EFCAB10        EF-hand calcium binding domain 10                                                         −2.10   1.14E-04          233.55
  NM_000639                FASLG          Fas ligand (TNF superfamily, member 6)                                                    −1.61   2.15E-04          274.72
  NM_001124                ADM            Adrenomedullin                                                                            −1.48   3.43E-04          311.18
  NM_000043                FAS            Fas (TNF receptor superfamily, member 6)                                                  −1.68   4.22E-04          329.27
  BC065002                 EXD3           Exonuclease 3′-5′ domain containing 3                                                     −2.04   5.19E-04          349.20
  NM_004931                CD8B           CD8b molecule                                                                             −1.24   6.82E-04          378.73
  NM_021635                PBOV1          Prostate and breast cancer overexpressed 1                                                −1.17   7.31E-04          386.63
  NM_000093                COL5A1         Collagen, type V, α1                                                                      −1.67   8.08E-04          398.60
  NM_000429                MAT1A          Methionine adenosyltransferase I, α                                                       −1.67   8.43E-04          403.54
  NM_000033                ABCD1          ATP-binding cassette, sub-family D (ALD), member 1                                        −1.69   8.92E-04          411.33
  NM_000125                ESR1           Estrogen receptor 1                                                                       −1.67   8.95E-04          411.64
  NM_000808                GABRA3         γ-Aminobutyric acid (GABA) A receptor, α3                                                 −1.60   9.27E-04          415.96
  NM_000595                LTA            Lymphotoxin-α (TNF superfamily, member 1)                                                 −1.63   9.95E-04          427.69
  NM_000197                HSD17B3        Hydroxysteroid (17-β) dehydrogenase 3                                                     −1.67   1.04E-03          432.79
  NM_001037442             RUFY3          RUN and FYVE domain containing 3                                                          −1.54   1.05E-03          434.60
  NM_000545                HNF1A          HNF1 homeobox A                                                                           −1.64   1.07E-03          437.31
  NM_001005490             OR6C74         Olfactory receptor, family 6, subfamily C, member 74                                      −1.59   1.09E-03          439.40
  NM_001031848             SERPINB8       Serpin peptidase inhibitor, clade B (ovalbumin), member 8                                 −1.54   1.15E-03          447.15
  NM_000612                IGF2           Insulin-like growth factor 2 (somatomedin A)                                              −1.63   1.16E-03          448.01
  NM_000517                HBA2           Hemoglobin, α2                                                                            −1.64   1.19E-03          451.63
  NM_001130861             CLDN5          Claudin 5                                                                                 −1.44   1.24E-03          458.33
  NM_001004688             OR2M2          Olfactory receptor, family 2, subfamily M, member 2                                       −1.59   1.24E-03          458.57
  NM_001030004             HNF4A          Hepatocyte nuclear factor 4, α                                                            −1.56   1.26E-03          460.62
  NM_001033952             CALCA          Calcitonin-related polypeptide α                                                          −1.54   1.26E-03          461.21
  NM_001010870             TDRD6          Tudor domain containing 6                                                                 −1.58   1.32E-03          466.23
  NM_001018025             MTCP1          Mature T cell proliferation 1                                                             −1.57   1.41E-03          475.20
  NM_001012967             DDX60L         DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like                                            −1.57   1.41E-03          475.20
  NM_001085                SERPINA3       Serpin peptidase inhibitor, clade A (α-1 antiproteinase, antitrypsin), member 3           −1.49   1.42E-03          476.63
  NM_000633                BCL2           B-cell CLL/lymphoma 2                                                                     −1.63   1.45E-03          479.53
  NM_001037666             GATSL3         GATS protein-like 3                                                                       −1.52   1.52E-03          486.52
  NM_001165                BIRC3          Baculoviral IAP repeat containing 3                                                       −1.42   1.58E-03          491.86
  NM_002247                KCNMA1         Potassium large conductance calcium-activated channel, subfamily M, α member 1            −1.33   1.94E-03          521.16
  NM_173625                C17ORF78       Chromosome 17 open reading frame 78                                                       −1.01   1.95E-03          521.61
  NM_001124759             FRG2C          FSHD region gene 2 family, member C                                                       −1.44   2.00E-03          524.95
  NM_001080453             INTS1          Integrator complex subunit 1                                                              −1.51   2.00E-03          524.88
  NM_004613                TGM2           Transglutaminase 2 (C polypeptide, protein-glutamine-γ-glutamyltransferase)               −1.24   2.14E-03          536.10
  NM_001044392             MUC1           Mucin 1, cell surface-associated                                                          −1.51   2.31E-03          548.26
  NM_001195127             WI2-2373I1.2   Forkhead box L1-like                                                                      −1.39   2.41E-03          556.59
  NM_001243042             HLA-C          Major histocompatibility complex, class I, C                                              −1.38   2.43E-03          558.50
  NM_001083602             PTCH1          Patched 1                                                                                 −1.49   2.58E-03          570.46
  NM_207352                CYP4V2         Cytochrome P450, family 4, subfamily V, polypeptide 2                                     −0.86   2.71E-03          579.03
  NR_029392                KRT16P2        Keratin 16 pseudogene 2                                                                   −0.54   2.97E-03          594.00
  NM_001172646             PLCB4          Phospholipase C, β4                                                                       −1.39   3.03E-03          598.52
  NM_002089                CXCL2          Chemokine (C-X-C motif) ligand 2                                                          −1.34   3.39E-03          620.43
  NM_001496                GFRA3          GDNF family receptor α3                                                                   −1.38   3.40E-03          620.75
  NM_001668                ARNT           Aryl hydrocarbon receptor nuclear translocator                                            −1.37   3.42E-03          622.12
  NM_021151                CROT           Carnitine O-octanoyltransferase                                                           −1.18   3.47E-03          624.70
  NM_001949                E2F3           E2F transcription factor 3                                                                −1.36   3.53E-03          628.70
  NM_002307                LGALS7         Lectin, galactoside-binding, soluble, 7                                                   −1.32   3.56E-03          630.07
  NM_001704                BAI3           Brain-specific angiogenesis inhibitor 3                                                   −1.37   3.57E-03          630.78
  NM_001978                DMTN           Erythrocyte membrane protein band 4.9 (dematin)                                           −1.35   3.62E-03          633.47
  NM_183001                SHC1           SHC (Src homology 2 domain containing) transforming protein 1                             −0.90   3.64E-03          634.32
  NM_001185156             IL24           Interleukin 24                                                                            −1.39   3.71E-03          637.18
  NM_004048                B2M            β-2-microglobulin                                                                         −1.27   3.73E-03          637.88
  NM_001004456             OR1M1          Olfactory receptor, family 1, subfamily M, member 1                                       −1.60   3.85E-03          644.36
  NM_002133                HMOX1          Heme oxygenase (decycling) 1                                                              −1.33   3.97E-03          649.35
  NM_002457                MUC2           Mucin 2, oligomeric mucus/gel-forming                                                     −1.31   4.02E-03          651.72
  NM_001198                PRDM1          PR domain containing 1, with ZNF domain                                                   −1.39   4.05E-03          653.14
  NM_001136022             NFATC4         Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4                 −1.43   4.06E-03          653.68
  NM_001454                FOXJ1          Horkhead box J1                                                                           −1.38   4.11E-03          656.34
  NM_002006                FGF2           Fibroblast growth factor 2 (basic)                                                        −1.35   4.11E-03          656.64
  NM_177996                EPB41L1        Erythrocyte membrane protein band 4.1-like 1                                              −0.97   4.19E-03          659.94
  NM_004417                DUSP1          Dual specificity phosphatase 1                                                            −1.25   4.38E-03          669.42
  NM_201282                EGFR           Epidermal growth factor receptor                                                          −0.88   4.53E-03          676.59
  NM_004416                DTX1           Deltex homolog 1 (*Drosophila*)                                                           −1.25   4.68E-03          682.88
  NM_003128                SPTBN1         Spectrin, β, non-erythrocytic 1                                                           −1.29   4.75E-03          685.70
  NM_001807                CEL            Carboxyl ester lipase (bile salt-stimulated lipase)                                       −1.36   4.94E-03          693.06
  NM_207336                ZNF467         Zinc finger protein 467                                                                   −0.86   4.95E-03          693.44
  NM_002381                MATN3          Matrilin 3                                                                                −1.32   5.00E-03          695.99
  NM_002317                LOX            Lysyl oxidase                                                                             −1.32   5.00E-03          696.01
  NM_024766                CAMKMT         Calmodulin-lysine N-methyltransferase                                                     −1.15   5.07E-03          699.15
  NM_003667                LGR5           Leucine-rich repeat containing G protein-coupled receptor 5                               −1.29   5.27E-03          707.84
  NM_002535                OAS2           2′-5′-Oligoadenylate synthetase 2, 69/71 kDa                                              −1.30   5.27E-03          708.15
  NM_145041                TMEM106A       Transmembrane protein 106A                                                                −1.10   5.27E-03          708.30
  NM_003061                SLIT1          Slit homolog 1 (*Drosophila*)                                                             −1.30   5.36E-03          711.28
  NM_013292                MYLPF          Myosin light chain, phosphorylatable, fast skeletal muscle                                −1.21   5.40E-03          712.71
  NM_004310                RHOH           Ras homolog gene family, member H                                                         −1.26   5.55E-03          719.34
  NM_002483                CEACAM6        Carcinoembryonic antigen-related cell adhesion molecule 6                                 −1.30   5.71E-03          725.32
  NM_005531                IFI16          Interferon, γ-inducible protein 16                                                        −1.23   5.87E-03          732.01
  NM_133471                PPP1R18        Protein phosphatase 1, regulatory subunit 18                                              −1.13   5.88E-03          732.45
  NM_006398                UBD            Ubiquitin D                                                                               −1.22   5.89E-03          732.86
  NM_004994                MMP9           Matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase)   −1.24   5.90E-03          733.00
  NR_003531                MEG3           Maternally expressed 3 (non-protein coding)                                               −0.79   5.98E-03          736.40
  NM_012171                TSPAN17        Tetraspanin 17                                                                            −1.22   6.10E-03          741.06
  NM_032599                FAM71F1        Family with sequence similarity 71, member F1                                             −1.14   6.13E-03          742.39
  NM_019074                DLL4           δ-like 4 (*Drosophila*)                                                                   −1.19   6.16E-03          743.53
  NM_002405                MFNG           MFNG O-fucosylpeptide 3-β-N-acetylglucosaminyltransferase                                 −1.31   6.30E-03          749.05
  NM_015000                STK38L         Serine/threonine kinase 38-like                                                           −1.21   6.32E-03          750.10
  NM_018416                FOXJ2          Forkhead box J2                                                                           −1.20   6.36E-03          751.65
  NM_016135                ETV7           Ets variant 7                                                                             −1.21   6.38E-03          752.29
  NM_015886                PI15           Peptidase inhibitor 15                                                                    −1.21   6.39E-03          752.62
  NM_002543                OLR1           Oxidized low density lipoprotein (lectin-like) receptor 1                                 −1.30   6.40E-03          752.88
  NM_005023                PGGT1B         Protein geranylgeranyltransferase type I, β-subunit                                       −1.24   6.53E-03          757.78
  NM_172390                NFATC1         Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1                 −1.02   6.57E-03          759.52
  NM_017766                CASZ1          Castor zinc finger 1                                                                      −1.20   6.78E-03          767.06
  NM_144633                KCNH8          Potassium voltage-gated channel, subfamily H (eag-related), member 8                      −1.12   6.86E-03          770.19
  NM_025125                TMEM254        Chromosome 10 open reading frame 57                                                       −1.14   6.87E-03          770.43
  NM_182909                FILIP1L        Filamin A interacting protein 1-like                                                      −0.92   6.89E-03          771.28
  NM_173503                EFCAB3         EF-hand calcium binding domain 3                                                          −1.02   6.92E-03          772.10
  NM_144673                CMTM2          CKLF-like MARVEL transmembrane domain containing 2                                        −1.12   6.95E-03          773.54
  NM_021819                LMAN1L         Lectin, mannose-binding, 1-like                                                           −1.17   6.95E-03          773.62
  NM_022804                SNURF          SNRPN upstream reading frame                                                              −1.16   6.99E-03          775.02
  NM_021633                KLHL12         Kelch-like 12 (*Drosophila*)                                                              −1.17   7.01E-03          775.60
  NM_021966                TCL1A          T cell leukemia/lymphoma 1A                                                               −1.16   7.23E-03          782.50
  NM_032637                SKP2           S phase kinase-associated protein 2 (p45)                                                 −1.14   7.27E-03          784.16
  NM_022648                TNS1           Tensin 1                                                                                  −1.16   7.32E-03          785.88
  NM_004213                SLC28A1        Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1                −1.27   7.46E-03          790.45
  NM_033088                STRIP1         Family with sequence similarity 40, member A                                              −1.14   7.49E-03          791.43
  NM_022304                HRH2           Histamine receptor H2                                                                     −1.16   7.62E-03          796.01
  NM_021105                PLSCR1         Phospholipid scramblase 1                                                                 −1.18   7.65E-03          797.28
  NM_024768                EFCC1          Coiled-coil domain containing 48                                                          −1.15   7.66E-03          797.48
  NM_006290                TNFAIP3        Tumor necrosis factor, α-induced protein 3                                                −1.22   7.68E-03          798.22
  NM_030639                BHLHB9         Basic helix-loop-helix domain containing, class B, 9                                      −1.14   7.69E-03          798.53
  NM_004246                GLP2R          Glucagon-like peptide 2 receptor                                                          −1.26   7.79E-03          802.00
  NM_032873                UBASH3B        Ubiquitin-associated and SH3 domain containing B                                          −1.14   7.79E-03          802.14
  NM_001963                EGF            Epidermal growth factor                                                                   −1.35   7.84E-03          803.92
  NM_052904                KLHL32         Kelch-like 32 (*Drosophila*)                                                              −1.13   7.89E-03          805.79
  NM_006125                ARHGAP6        Rho GTPase activating protein 6                                                           −1.23   7.90E-03          806.11
  NM_032772                ZNF503         Zinc finger protein 503                                                                   −1.14   7.95E-03          807.90
  NM_024886                C10orf95       Chromosome 10 open reading frame 95                                                       −1.15   7.99E-03          809.09
  NM_152703                SAMD9L         Sterile α motif domain containing 9-like                                                  −1.09   8.02E-03          809.77
  NM_032752                ZNF496         Zinc finger protein 496                                                                   −1.14   8.03E-03          810.31
  NM_138456                BATF2          Basic leucine zipper transcription factor, ATF-like 2                                     −1.13   8.04E-03          810.45
  NM_172370                DAOA           D-amino acid oxidase activator                                                            −1.04   8.07E-03          811.67
  NM_005747                CELA3A         Chymotrypsin-like elastase family, member 3A                                              −1.23   8.07E-03          811.75
  NM_033101                LGALS12        Lectin, galactoside-binding, soluble, 12                                                  −1.14   8.14E-03          813.87
  NM_012224                NEK1           NIMA (never in mitosis gene a)- related kinase 1                                          −1.21   8.21E-03          816.40
  NM_020436                SALL4          Sal-like 4 (*Drosophila*)                                                                 −1.19   8.31E-03          819.74
  NM_138980                MAPK10         Mitogen-activated protein kinase 10                                                       −1.13   8.34E-03          820.62
  NM_020896                OSBPL5         Oxysterol binding protein-like 5                                                          −1.18   8.41E-03          822.84
  NM_052897                MBD6           Methyl-CpG binding domain protein 6                                                       −1.14   8.52E-03          826.04
  NM_207419                C1QTNF8        C1q and tumor necrosis factor related protein 8                                           −0.82   8.58E-03          827.94
  NM_005933                KMT2A          myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, *Drosophila*)              −1.23   8.59E-03          828.40
  NM_181712                KANK4          KN motif and ankyrin repeat domains 4                                                     −0.96   8.61E-03          828.96
  NM_017777                MKS1           Meckel syndrome, type 1                                                                   −1.20   8.61E-03          829.20
  NM_176677                NHLRC4         NHL repeat containing 4                                                                   −0.99   8.67E-03          831.05
  NM_025130                HKDC1          Hexokinase domain containing 1                                                            −1.14   8.71E-03          832.53
  NM_017654                SAMD9          Sterile α motif domain containing 9                                                       −1.21   8.92E-03          838.42
  NM_052864                TIFA           TRAF-interacting protein with forkhead-associated domain                                  −1.14   8.94E-03          838.99
  NM_015569                DNM3           Dynamin 3                                                                                 −1.21   8.95E-03          839.17
  NM_139047                               Mitogen-activated protein kinase 8                                                        −1.12   8.99E-03          840.70
  NM_207173                NPSR1          Neuropeptide S receptor 1                                                                 −0.87   9.03E-03          841.91
  NM_015444                TMEM158        Transmembrane protein 158 (gene/pseudogene)                                               −1.21   9.03E-03          841.90
  NM_017523                XAF1           XIAP-associated factor 1                                                                  −1.21   9.10E-03          844.23
  NM_006931                SLC2A3         Solute carrier family 2 (facilitated glucose transporter), member 3                       −1.22   9.11E-03          844.45
  NM_019018                FAM105A        Family with sequence similarity 105, member A                                             −1.19   9.13E-03          845.15
  NM_153042                KDM1B          Lysine (K)-specific demethylase 1B                                                        −1.08   9.18E-03          846.40
  NM_033056                PCDH15         Protocadherin-related 15                                                                  −1.14   9.23E-03          848.31
  NM_014157                CCDC113        Coiled-coil domain containing 113                                                         −1.21   9.25E-03          848.53
  NM_144962                PEBP4          Phosphatidylethanolamine-binding protein 4                                                −1.12   9.31E-03          850.61
  NM_145862                CHEK2          Checkpoint kinase 2                                                                       −1.09   9.36E-03          852.29
  NM_182524                ZNF595         Zinc finger protein 595                                                                   −0.93   9.41E-03          853.59
  NM_014858                TMCC2          Transmembrane and coiled-coil domain family 2                                             −1.21   9.46E-03          855.35
  NM_144990                SLFNL1         Schlafen-like 1                                                                           −1.11   9.47E-03          855.60
  NM_022147                RTP4           Receptor (chemosensory) transporter protein 4                                             −1.16   9.49E-03          856.25
  NM_022873                IFI6           Interferon, α-inducible protein 6                                                         −1.16   9.73E-03          863.03
  NM_152685                SLC23A1        Solute carrier family 23 (nucleobase transporters), member 1                              −1.09   9.73E-03          863.10
  NM_152278                TCEAL7         Transcription elongation factor A (SII)-like 7                                            −1.09   9.84E-03          866.45
  NM_019035                PCDH18         Protocadherin 18                                                                          −1.19   9.95E-03          869.75
  NM_153183                NUDT10         Nudix (nucleoside diphosphate linked moiety X)-type motif 10                              −1.07   9.99E-03          870.83

###### 

Significant functional categories of upregulated and downregulated genes.

  A, Upregulated genes                                                          
  ----------------------------------------------- --------- --------- --------- ---------
  GO category                                                                   
    Cell fate commitment                          7.2E-07   8.9E-04   8.9E-04   1.2E-03
    Negative regulation of cell differentiation   2.9E-05   3.5E-02   1.2E-02   4.7E-02
    Differentiation                               6.8E-05   1.7E-02   1.7E-02   8.8E-02
    Developmental protein                         9.2E-05   2.4E-02   1.2E-02   1.2E-01
    Notch signaling pathway                       1.0E-04   2.6E-02   8.7E-03   1.3E-01
    Intestine                                     2.4E-04   6.0E-02   1.5E-02   3.1E-01
  KEGG pathway                                                                  
    Notch signaling pathway                       3.5E-05   2.7E-03   2.7E-03   3.7E-02
  B, Downregulated genes                                                        
  GO category                                                                   
    Regulation of cell death                      5.9E-07   9.2E-04   4.6E-04   9.8E-04
    Regulation of cell proliferation              1.8E-04   2.4E-01   1.9E-02   2.9E-01
    Regulation of cell migration                  2.0E-04   2.7E-01   1.9E-02   3.3E-01
  KEGG pathway                                                                  
    Pathways in cancer                            1.9E-04   1.6E-02   1.6E-02   2.1E-01

GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; FDR, false discovery rate.
